Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Carolyn Vachani RN, MSN, AOCN
Ultima Vez Modificado: 18 de noviembre del 2006
Locally advanced squamous cell head and neck cancer is often treated with a combination of cisplatin chemotherapy and radiation therapy. The dose of cisplatin is limited by the side effects it causes. By giving chemotherapy into an artery near the tumor (carotid artery), and giving a drug to counteract the cisplatin's effects in other areas of the body, the cisplatin dose that can be safely given is significantly higher, and thus perhaps more drug will reach the tumor. Two- hundred and forty patients with T3 or T4 tumors were randomly assigned to receive chemotherapy either intravenously (traditional IV) or intra-arterially (via carotid artery in the neck). The results revealed no difference in the development of metastatic disease or in overall survival.
This study was conducted in the Netherlands and used an intra-arterial technique that was different from the technique used in the US, namely there was less bilateral artery infusion, which may mean not enough chemotherapy drug was given. The moderator of the presentation felt this may have resulted in the lack of improvement in outcome with the intra-arterial technique.
This trial was done to determine whether the addition of gemcitabine to postoperative 5-FU, along with radiation, would improve outcomes in patients with resected pancreatic adenocarcinomas. Numerous studies have shown that there are considerable differences in the way radiation is planned and delivered for pancreatic cancer. Previous studies have suggested that the quality of the radiation given directly impacts patient outcomes. This analysis of the previous study's data was performed to see if a correlation exists between the quality of radiation therapy and patient survival.
Patients had non-metastatic disease with 0 or 1 lymph node involved, and had all undergone surgical resection. Radiation was scored by the investigators as: 1) per protocol, 2) variation acceptable, 3) variation unacceptable, or 4) data incomplete to analyze. Patients who were considered to have received radiation per protocol had significantly improved survival compared to patients who did not. In this study, radiation quality significantly impacted the outcomes for patients with pancreatic cancer.
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults